Biju B Thomas1,2, Danhong Zhu3,4, Tai-Chi Lin3,5,6,7, Young Chang Kim3,4, Magdalene J Seiler8,9, Juan Carlos Martinez-Camarillo3,5, Bin Lin8,9, Yousuf Shad10, David R Hinton3,4, Mark S Humayun3,5. 1. Department of Ophthalmology, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, 90033, USA. biju.thomas@med.usc.edu. 2. USC Institute for Biomedical Therapeutics, University of Southern California, Los Angeles, CA, USA. biju.thomas@med.usc.edu. 3. Department of Ophthalmology, USC Roski Eye Institute, University of Southern California, Los Angeles, CA, 90033, USA. 4. Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. 5. USC Institute for Biomedical Therapeutics, University of Southern California, Los Angeles, CA, USA. 6. Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China. 7. Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China. 8. Department of Physical Medicine & Rehabilitation, University of California-Irvine, Irvine, CA, USA. 9. Stem Cell Research Center, University of California-Irvine, Irvine, CA, USA. 10. Department of Chemistry and Chemical Biology, McMaster University, Hamilton, ON, Canada.
Abstract
PURPOSE: To create new immunodeficient Royal College of Surgeons (RCS) rats by introducing the defective MerTK gene into athymic nude rats. METHODS: Female homozygous RCS (RCS-p+/RCS-p+) and male nude rats (Hsd:RH-Foxn1mu, mutation in the foxn1 gene; no T cells) were crossed to produce heterozygous F1 progeny. Double homozygous F2 progeny obtained by crossing the F1 heterozygotes was identified phenotypically (hair loss) and genotypically (RCS-p+ gene determined by PCR). Retinal degenerative status was confirmed by optical coherence tomography (OCT) imaging, electroretinography (ERG), optokinetic (OKN) testing, superior colliculus (SC) electrophysiology, and by histology. The effect of xenografts was assessed by transplantation of human embryonic stem cell-derived retinal pigment epithelium (hESC-RPE) and human-induced pluripotent stem cell-derived RPE (iPS-RPE) into the eye. Morphological analysis was conducted based on hematoxylin and eosin (H&E) and immunostaining. Age-matched pigmented athymic nude rats were used as control. RESULTS: Approximately 6% of the F2 pups (11/172) were homozygous for RCS-p+ gene and Foxn1mu gene. Homozygous males crossed with heterozygous females resulted in 50% homozygous progeny for experimentation. OCT imaging demonstrated significant loss of retinal thickness in homozygous rats. H&E staining showed photoreceptor thickness reduced to 1-3 layers at 12 weeks of age. Progressive loss of visual function was evidenced by OKN testing, ERG, and SC electrophysiology. Transplantation experiments demonstrated survival of human-derived cells and absence of apparent immune rejection. CONCLUSIONS: This new rat animal model developed by crossing RCS rats and athymic nude rats is suitable for conducting retinal transplantation experiments involving xenografts.
PURPOSE: To create new immunodeficient Royal College of Surgeons (RCS) rats by introducing the defective MerTK gene into athymic nude rats. METHODS: Female homozygous RCS (RCS-p+/RCS-p+) and male nude rats (Hsd:RH-Foxn1mu, mutation in the foxn1 gene; no T cells) were crossed to produce heterozygous F1 progeny. Double homozygous F2 progeny obtained by crossing the F1 heterozygotes was identified phenotypically (hair loss) and genotypically (RCS-p+ gene determined by PCR). Retinal degenerative status was confirmed by optical coherence tomography (OCT) imaging, electroretinography (ERG), optokinetic (OKN) testing, superior colliculus (SC) electrophysiology, and by histology. The effect of xenografts was assessed by transplantation of human embryonic stem cell-derived retinal pigment epithelium (hESC-RPE) and human-induced pluripotent stem cell-derived RPE (iPS-RPE) into the eye. Morphological analysis was conducted based on hematoxylin and eosin (H&E) and immunostaining. Age-matched pigmented athymic nude rats were used as control. RESULTS: Approximately 6% of the F2 pups (11/172) were homozygous for RCS-p+ gene and Foxn1mu gene. Homozygous males crossed with heterozygous females resulted in 50% homozygous progeny for experimentation. OCT imaging demonstrated significant loss of retinal thickness in homozygous rats. H&E staining showed photoreceptor thickness reduced to 1-3 layers at 12 weeks of age. Progressive loss of visual function was evidenced by OKN testing, ERG, and SC electrophysiology. Transplantation experiments demonstrated survival of human-derived cells and absence of apparent immune rejection. CONCLUSIONS: This new rat animal model developed by crossing RCS rats and athymic nude rats is suitable for conducting retinal transplantation experiments involving xenografts.
Authors: Anat Yanai; Urs O Häfeli; Andrew L Metcalfe; Peter Soema; Lois Addo; Cheryl Y Gregory-Evans; Kelvin Po; Xianghong Shan; Orson L Moritz; Kevin Gregory-Evans Journal: Cell Transplant Date: 2012-03-08 Impact factor: 4.064
Authors: D Cibulskyte; H Kaalund; M Pedersen; A Hørlyck; N Marcussen; H E Hansen; M Madsen; J Mortensen Journal: Transplant Proc Date: 2005-10 Impact factor: 1.066
Authors: Jason S Meyer; Sara E Howden; Kyle A Wallace; Amelia D Verhoeven; Lynda S Wright; Elizabeth E Capowski; Isabel Pinilla; Jessica M Martin; Shulan Tian; Ron Stewart; Bikash Pattnaik; James A Thomson; David M Gamm Journal: Stem Cells Date: 2011-08 Impact factor: 6.277
Authors: P M D'Cruz; D Yasumura; J Weir; M T Matthes; H Abderrahim; M M LaVail; D Vollrath Journal: Hum Mol Genet Date: 2000-03-01 Impact factor: 6.150
Authors: Bin Lin; Bryce T McLelland; Robert B Aramant; Biju B Thomas; Gabriel Nistor; Hans S Keirstead; Magdalene J Seiler Journal: Invest Ophthalmol Vis Sci Date: 2020-09-01 Impact factor: 4.799
Authors: Biju B Thomas; Bin Lin; Juan Carlos Martinez-Camarillo; Danhong Zhu; Bryce T McLelland; Gabriel Nistor; Hans S Keirstead; Mark S Humayun; Magdalene J Seiler Journal: Front Neurosci Date: 2021-10-26 Impact factor: 4.677
Authors: Deepthi S Rajendran Nair; Danhong Zhu; Ruchi Sharma; Juan Carlos Martinez Camarillo; Kapil Bharti; David R Hinton; Mark S Humayun; Biju B Thomas Journal: Cells Date: 2021-10-29 Impact factor: 6.600
Authors: Ian C Han; Laura R Bohrer; Katherine N Gibson-Corley; Luke A Wiley; Arwin Shrestha; Brynnon E Harman; Chunhua Jiao; Elliott H Sohn; Rion Wendland; Brittany N Allen; Kristan S Worthington; Robert F Mullins; Edwin M Stone; Budd A Tucker Journal: Cell Transplant Date: 2022 Jan-Dec Impact factor: 4.139
Authors: Céline Koster; Kimberley E Wever; Philip E Wagstaff; Koen T van den Hirk; Carlijn R Hooijmans; Arthur A Bergen Journal: Int J Mol Sci Date: 2020-04-14 Impact factor: 5.923